echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Infection > AB201 as a potential therapy for COVID-19: FDA Fast Track Certified

    AB201 as a potential therapy for COVID-19: FDA Fast Track Certified

    • Last Update: 2020-12-12
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Biopharmaceutical company ARCA announced today that AB201, a potential treatment for COVID-19, has been fast-track certified by the U.S. Food and Drug Administration (FDA).
    plans to launch AB201 Phase IIb Clinical Trials (ASPEN-COVID-19) in approximately 100 COVID-19 inpatients in December 2020, with top-line trial data expected in the second quarter of 2021.
    according to the FDA's Fast Track Guidelines document, the Fast Track Program aims to facilitate and accelerate the review of new drugs designed to treat serious or life-threatening diseases and demonstrate the potential to meet medical needs.
    AB201 is an effective tissue factor (TF) selective inhibitor, a small recombinant protein that is being developed as a potential treatment for RNA virus-related diseases, initially focusing on COVID-19.
    has been identified as playing an important role in combating the inflammatory response to viral infections and virus transmission.
    its unique mechanism of action to make AB201 anticoagulant, anti-inflammatory and anti-viral properties, so it is possible to effectively address the impact of a variety of ways on viral infections.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.